| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Affymax, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0007 |
| 52 Week High | US$0.04 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -66.67% |
| 1 Year Change | -98.25% |
| 3 Year Change | -99.18% |
| 5 Year Change | -96.96% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| AFFY | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -3.7% |
| 1Y | -98.3% | -2.0% | 20.5% |
Return vs Industry: AFFY underperformed the US Biotechs industry which returned -2% over the past year.
Return vs Market: AFFY underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| AFFY volatility | |
|---|---|
| AFFY Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AFFY's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AFFY's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Jon Couchman | www.affymax.com |
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Affymax, Inc. Fundamentals Summary
| AFFY fundamental statistics | |
|---|---|
| Market cap | US$26.24k |
| Earnings (TTM) | US$3.07m |
| Revenue (TTM) | US$42.00k |
0.0x
P/E Ratio0.0x
P/S RatioIs AFFY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFFY income statement (TTM) | |
|---|---|
| Revenue | US$42.00k |
| Cost of Revenue | -US$167.00k |
| Gross Profit | US$209.00k |
| Other Expenses | -US$2.86m |
| Earnings | US$3.07m |
Last Reported Earnings
Jun 30, 2014
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AFFY perform over the long term?
See historical performance and comparison